(NASDAQ: GLPG) Galapagos Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Galapagos Nv's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast GLPG's revenue for 2025 to be $12,714,180,879, with the lowest GLPG revenue forecast at $11,332,978,271, and the highest GLPG revenue forecast at $14,095,383,487. On average, 2 Wall Street analysts forecast GLPG's revenue for 2026 to be $2,574,269,079, with the lowest GLPG revenue forecast at $1,752,203,118, and the highest GLPG revenue forecast at $3,396,335,039.
In 2027, GLPG is forecast to generate $1,790,423,419 in revenue, with the lowest revenue forecast at $1,790,423,419 and the highest revenue forecast at $1,790,423,419.